AP NEWS

Global Prostate Cancer Therapeutics Market to Reach $15.6 Billion by 2023 - Analysis Featuring AstraZeneca, Sanofi-Aventis, Ipsen, Tolmar, Abbott, BMS, and Many More - ResearchAndMarkets.com

October 1, 2018

DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Prostate Cancer Therapeutics Market - by Therapy, Drugs, Distribution, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017- 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global prostate cancer therapeutics market will reach 15.6 billion USD by 2023 from 9.8 billion USD in 2017 with a CAGR of 8.06% during the forecast period.

The rising incidences of prostate cancer is fueling the market growth. Adoption of various technologies in diagnostics test is as key factor for the growth of the market. On the other hand, high cost of treatment is hindering the growth of the market.

North America will be the leading contributor to the market during the forecast period due to increasing prostate cancer patients and high investments in R&D. Asia Pacific and Latin America are predicted to display significant growth in the market due to rising awareness about the disease.

Industry Trends & Updates

Clinical Laserthermia Systems and Exact Imaging are joining forces to market image-guided laser surgery to treat prostate cancer and benign prostatic hyperplasia MDxHealth announced that it has signed a worldwide licensing agreement with Philips for the rights to manufacture and market Philips’ recently validated phosphodiesterase-4D7 prostate cancer biomarker as a prognostic test.

Companies Profiled

AstraZeneca Sanofi-Aventis Ipsen Tolmar Abbott Astellas Pharma Indevus Dendreon Ferring Bristol-Myers Squibb Pfizer Sanofi Teva Takeda Johnson & Johnson

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Prostate Cancer Therapeutics Market Segmentation, Forecasts and Trends - by Therapy

6. Global Prostate Cancer Therapeutics Market Segmentation, Forecasts and Trends - by Drugs

7. Global Prostate Cancer Therapeutics Market Segmentation, Forecasts and Trends - by Distribution

8. Global Prostate Cancer Therapeutics Market Segmentation, Forecasts and Trends - by Region

9. Company Market Share Analysis

10. Company Profiles

11. Industry Structure

12. Global Prostate Cancer Therapeutics Market - The Road Ahead

For more information about this report visit https://www.researchandmarkets.com/research/gd9c49/global_prostate?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005632/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Prostate Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/01/2018 10:15 AM/DISC: 10/01/2018 10:16 AM

http://www.businesswire.com/news/home/20181001005632/en

AP RADIO
Update hourly